Doximity, Inc. $DOCS Shares Acquired by Robeco Institutional Asset Management B.V.

Key Points

• Robeco Institutional Asset Management B.V. increased its stake in Doximity, Inc. by 98.7%, acquiring an additional 102,401 shares in Q2, bringing its total to 206,124 shares valued at approximately $12.6 million.
• Several other institutional investors have also boosted their holdings in Doximity, indicating high interest, with hedge funds collectively owning 87.19% of the company's stock.
• Doximity's stock received varied analyst ratings, including upgrades to an "outperform" rating with increased price targets, reflecting a consensus rating of "Moderate Buy" and an average target price of $68.16.

Robeco Institutional Asset Management B.V. increased its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 98.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 206,124 shares of the company's stock after buying an additional 102,401 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.11% of Doximity worth $12,644,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in the business. VSM Wealth Advisory LLC purchased a new stake in Doximity in the first quarter valued at $29,000. Allworth Financial LP raised its holdings in Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after buying an additional 287 shares during the period. National Bank of Canada FI purchased a new stake in Doximity in the 1st quarter valued at about $33,000. Spire Wealth Management lifted its position in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after buying an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group boosted its stake in Doximity by 70.7% during the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after buying an additional 309 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DOCS has been the topic of a number of research analyst reports. Zacks Research downgraded shares of Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Evercore ISI upgraded Doximity from an "in-line" rating to an "outperform" rating and upped their price target for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Wells Fargo & Company raised their price target on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Monday, August 4th. KeyCorp boosted their price objective on Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Finally, Truist Financial increased their target price on Doximity from $52.00 to $61.00 and gave the stock a "hold" rating in a research note on Thursday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $68.16.

Insider Transactions at Doximity

In related news, Director Regina M. Benjamin sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $70.50, for a total transaction of $352,500.00. Following the transaction, the director owned 19,839 shares in the company, valued at $1,398,649.50. This trade represents a 20.13% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director owned 16,618 shares of the company's stock, valued at approximately $948,721.62. This represents a 10.74% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 37,000 shares of company stock worth $2,581,880. Corporate insiders own 31.30% of the company's stock.

Doximity Trading Up 1.7%

DOCS stock opened at $73.25 on Friday. The stock has a market cap of $13.72 billion, a P/E ratio of 73.25, a PEG ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a twelve month low of $40.87 and a twelve month high of $85.21. The company's 50 day moving average is $67.25 and its two-hundred day moving average is $60.70.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same period in the previous year, the business posted $0.28 earnings per share. The business's revenue for the quarter was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.